Interasma

Interasma is the Global Asthma Association focused on all aspects of asthma which bridges the gap between academia and the world of clinical practice.

[Juan C Ivancevich MD @Aller_MD]

Adults with #COPD and an #eosinophilic #phenotype had lower exposure to #systemic #corticosteroids in a year with add-on #mepolizumab vs. placebo, according to findings presented at the #CHEST Annual Meeting. https://t.co/Kc29XTbbmQ

[Juan C Ivancevich MD @Aller_MD]

Black race and ethnicity were the single strongest risk factor for developing harmful inflammation responsible for "T2-high asthma." Children with this type of asthma tend to suffer from frequent asthma attacks and often have difficult-to-manage symptoms.
https://t.co/mnf2nhVaC7

[Juan C Ivancevich MD @Aller_MD]

#Omalizumab Tied to Lower #Heart Disease Risk in #Chronic #Spontaneous #Urticaria: Patients with chronic spontaneous urticaria treated with omalizumab have a lower cardiovascular disease risk than those treated with oral corticosteroids or antihistamines. https://t.co/bFkpXM2AJZ

[Juan C Ivancevich MD @Aller_MD]

Management of #Food #Allergy #Anaphylaxis in Urgent Care Settings ... and Beyond. CME. https://t.co/bx1FR6uqd6

[Juan C Ivancevich MD @Aller_MD]

#Maternal #Vaccination vs #Nirsevimab Use and #Respiratory #Syncytial #Virus Infection Among Full-Term Infants. Open Access. https://t.co/kEG8SPjbVE

[Juan C Ivancevich MD @Aller_MD]

#FDA approves #Orladeyo #berotralstat #pellets for #hereditary #angioedema in older age groups. https://t.co/6XxVmoStpN

[Juan C Ivancevich MD @Aller_MD]

Scientists propose national #microbiome plan to prevent #chronic #disease: leading microbiome researchers, have suspected that disruptions of microbial communities may explain the simultaneous rise of #obesity, #asthma and #food allergies. https://t.co/WQsM8tNpTZ

[Juan C Ivancevich MD @Aller_MD]

Patients report waiting a mean of 14 years for an #IL-1-mediated #autoinflammatory diagnosis. What to recognize, when to test, and how to use IL-1 blockade. https://t.co/5g7uZ0b32E

[Juan C Ivancevich MD @Aller_MD]

#Food #Allergy Self-Reports May Outpace Test Confirmation: Romanian adults report food allergy more often than they confirm it, and fewer than half name #adrenaline for #anaphylaxis. https://t.co/j2wT5ipEQL

[Juan C Ivancevich MD @Aller_MD]

In this video, James Fernandez, MD, PhD, explains the differences between #gene #therapy and gene #editing and how these techniques could be used in #primary #immunodeficiency care.
https://t.co/etbkj2yt66

[Juan C Ivancevich MD @Aller_MD]

#Contact #Dermatitis & #Patch #Testing: 2026 Updates for #Allergists (AAN) | College Learning Connection. https://t.co/bk12N5VBgi

[Juan C Ivancevich MD @Aller_MD]

#Dupilumab Use During #Pregnancy Appeared Safe for Babies - Prospective registry study shows no increase in birth defects.
https://t.co/VnvBxF0Hr3

[World Allergy Organization @worldallergy]

#WAOJournal: Evaluating the role of #ChatGPT in patient questions regarding #drug #allergies. Open Access. https://t.co/ZJpIvOHhmo

[Interasma @Interasma]

Prevalence and risk factors of #cough #variant #asthma in patients with #chronic #cough after #COVID-19: findings from the real-world data. Open Access. https://t.co/MUtuPlakNE

[Interasma @Interasma]

#Neuropsychiatric outcomes after #montelukast versus #inhaled #corticosteroids in pediatric #asthma: a pooled birth cohort study. Open Access. https://t.co/60XMP2QtG2

[Juan C Ivancevich MD @Aller_MD]

Adults with #asthma who used #proton #pump #inhibitors had greater risks for #exacerbations and other negative outcomes than those who did not, according to an abstract presented at the #CHEST Annual Meeting.
https://t.co/vkRvdpXUR7

[Juan C Ivancevich MD @Aller_MD]

#Ianalumab for the Treatment of Patients with #Sjögren’s #Disease | NEJM https://t.co/hnYGFI3WgU

[Juan C Ivancevich MD @Aller_MD]

Patients who used #depemokimab for uncontrolled #asthma experienced improved symptoms, activity, impact on daily life and well-being through 52 weeks, according to a poster presented at the #CHEST Annual Meeting. https://t.co/sJC2Anpl7m

[Juan C Ivancevich MD @Aller_MD]

#Tezepelumab significantly improved histologic #remission and #dysphagia symptoms at 24 and 52 weeks compared with placebo among individuals with #eosinophilic #esophagitis. https://t.co/clF7nS96KQ

[Juan C Ivancevich MD @Aller_MD]

A #prescription-only, superpotent #corticosteroid was found in one-third of select #OTC products purchased online in the United States for inflammatory skin conditions, according to a study published in #JAMA Network Open.
https://t.co/GrLLU6dwEC